- Home
- MNDR vs BDRX Comparison
MNDR vs BDRX Comparison
Compare MNDR & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNDR
- BDRX
- Stock Information
- Founded
- MNDR 2016
- BDRX 2000
- Country
- MNDR Singapore
- BDRX United Kingdom
- Employees
- MNDR N/A
- BDRX N/A
- Industry
- MNDR
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- MNDR
- BDRX Health Care
- Exchange
- MNDR Nasdaq
- BDRX Nasdaq
- Market Cap
- MNDR 6.8M
- BDRX 5.8M
- IPO Year
- MNDR 2024
- BDRX N/A
- Fundamental
- Price
- MNDR $1.12
- BDRX $0.90
- Analyst Decision
- MNDR
- BDRX
- Analyst Count
- MNDR 0
- BDRX 0
- Target Price
- MNDR N/A
- BDRX N/A
- AVG Volume (30 Days)
- MNDR 207.2K
- BDRX 3.2M
- Earning Date
- MNDR 06-16-2025
- BDRX 04-11-2025
- Dividend Yield
- MNDR N/A
- BDRX N/A
- EPS Growth
- MNDR N/A
- BDRX N/A
- EPS
- MNDR N/A
- BDRX N/A
- Revenue
- MNDR $11,600,567.00
- BDRX N/A
- Revenue This Year
- MNDR $188,831.77
- BDRX N/A
- Revenue Next Year
- MNDR $76.44
- BDRX N/A
- P/E Ratio
- MNDR N/A
- BDRX N/A
- Revenue Growth
- MNDR 0.61
- BDRX N/A
- 52 Week Low
- MNDR $1.05
- BDRX $0.78
- 52 Week High
- MNDR $12.72
- BDRX $41.50
- Technical
- Relative Strength Index (RSI)
- MNDR N/A
- BDRX 39.25
- Support Level
- MNDR N/A
- BDRX $0.85
- Resistance Level
- MNDR N/A
- BDRX $0.97
- Average True Range (ATR)
- MNDR 0.00
- BDRX 0.11
- MACD
- MNDR 0.00
- BDRX -0.00
- Stochastic Oscillator
- MNDR 0.00
- BDRX 28.24
About MNDR Mobile-health Network Solutions Class A Ordinary Shares
Mobile-health Network Solutions is a company engaged in providing telehealth solutions in terms of various matrices, such as the number of patient consultations per day and the ranking of its mobile application. It provides services on its MaNaDr platform, which is accessible via mobile application and website. The MaNaDr platform is a platform designed and created by doctors, for doctors and users, equipped with services like consultations with doctors, e-commerce pharma store, and others. The company's operating segments are Telemedicine and other services which is also its key revenue generating segment, and Sale of medicine and medical devices. Geographically, it derives revenue from Singapore.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.